HSCT Graft vs Host Disease (GVHD)
There is a knowledge deficit in the pathophysiology, morbidity, mortality, and treatment options associated with GVHD. Gaps in knowledge can lead to slower recognition, treatment, and advocacy for this patient population. Since immunosuppression is currently the mainstay of treatment these patients are at increased risk for infection and other secondary complications from acute and chronic GVH.
Estimated Duration of Course:
This offering carries 1.00 ANCC nursing contact hour.
The target audience is RNs, APPs, and those providing direct clinical care to this patient population.
- Describe the pathophysiology and diagnosis of patients with acute and chronic GVH.
- List the treatment options related to the care of a patient experiencing GVHD.
The Norman Knight Nursing Center
Please visit our website at mghpcs.org/KnightCenter
Course version: 6.2021
Zachariah DeFilipp, MD
Patricia Crispi PhD(c), RN, NPD-BC
Giuliana De Marchi, NP
Maria Alfonso, RN
Colleen Walsh, RN
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.